Kingworld Medicines Group Ltd. ( (HK:1110) ) has provided an update.
Kingworld Medicines Group Ltd. reported its annual results for the year ended December 31, 2024, showing a slight decrease in revenue by 1.6% to approximately RMB1,061,082,000. Despite the decline in gross profit and margin, the company experienced a notable increase in profit before taxation by 1.7% and a significant rise in profit for the year by 20.9% to RMB74,466,000. The board recommended a final dividend of HK3.17 cents per share, pending shareholder approval.
More about Kingworld Medicines Group Ltd.
YTD Price Performance: 1.09%
Average Trading Volume: 948,655
Technical Sentiment Signal: Buy
Current Market Cap: HK$282M
Find detailed analytics on 1110 stock on TipRanks’ Stock Analysis page.